Thomas BieringerSVP, Global Head of AMES at Bayer
Agenda Sessions
Keynote: Partnering to Enable Industrialization of Allogeneic Cell Therapy
, 8:30amView SessionKeynote: Partnering to Enable Industrialization of Allogeneic Cell Therapy
, 8:30amView SessionKeynote: Partnering to Enable Industrialization of Allogeneic Cell Therapy
, 8:30amView Session